Skip to content
Peptide research

NA-Selank Amidate

Also known as N-Acetyl Selank Amidate · Acetylated Selank
Category
Brain & Cognition
Administration routes
Nasal
Regulatory status
Not FDA-approved

What it is

A stabilized analog of Selank, marketed for calming anxiety without sedation or dependence. Human evidence is only moderate and mostly borrowed from the parent molecule; BDNF and antidepressant claims are animal or mechanism only. No trials exist on this exact form, so human safety data is essentially absent, with unresolved immune and serotonergic questions. Not an approved drug in the US or Europe, and supply is unregulated research-grade material.

Read Full record

Studied uses & evidence

Studied uses(6)

  • Anxiolytic effects comparable to benzodiazepines without sedation or dependence risk

    Medium

    Small non-blinded trials of parent Selank, not this analog, matched benzodiazepine anxiolysis; dependence untested.

  • Rapid elevation of BDNF expression in hippocampus

    Low

    Rat studies show parent Selank regulates hippocampal BDNF; no human or NA-amidate data exist.

  • Immunomodulatory effects — IL-6 modulation, T-helper cell cytokine balance

    Medium

    Human data limited to lab-cultured cells and one small uncontrolled trial; animal evidence is consistent.

Evidence limits

Evidence Level
Very Limited Evidence

Selank (the parent compound) is registered in Russia as an anxiolytic supplied as nonprescription nasal drops and has been studied in several Russian clinical trials for anxiety and cognitive disorders. English-language clinical data is scarce — most published studies are pilot studies or have only abstracts available in English. NA-Selank Amidate specifically has not been tested in clinical trials. The modifications are expected to enhance stability without altering the pharmacological profile significantly, but this has not been clinically validated.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(3)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Limited safety data (no formal clinical trials on the NA-Amidate form)

    Moderate
  • Potential immunomodulatory effects (IL-6, cytokine balance)

    Moderate
  • Possible serotonergic interactions

    Theoretical
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.